Immunocore Holdings (IMCR) Share-based Compensation Growth (3y) (2024 - 2026)

Immunocore Holdings (IMCR) Share-based Compensation Growth (3y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 244.08%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -50.27%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -0.04%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 38.45%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immunocore Holdings 1.80 Bn 957.43 Mn 106.24 Mn -8.62%

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.62%
Dec 31, 2025 1.13%
Sep 30, 2025 11.06%
Jun 30, 2025 2.43%
Dec 31, 2024 -9.67%
Sep 30, 2024 -19.73%